Bio-Techne (TECH) Total Current Liabilities (2016 - 2025)
Bio-Techne has reported Total Current Liabilities over the past 16 years, most recently at $140.4 million for Q4 2025.
- Quarterly results put Total Current Liabilities at $140.4 million for Q4 2025, down 12.92% from a year ago — trailing twelve months through Dec 2025 was $140.4 million (down 12.92% YoY), and the annual figure for FY2025 was $175.8 million, up 10.33%.
- Total Current Liabilities for Q4 2025 was $140.4 million at Bio-Techne, down from $144.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for TECH hit a ceiling of $176.0 million in Q2 2022 and a floor of $127.8 million in Q3 2023.
- Median Total Current Liabilities over the past 5 years was $143.3 million (2024), compared with a mean of $148.1 million.
- Biggest five-year swings in Total Current Liabilities: soared 42.76% in 2021 and later dropped 26.99% in 2023.
- Bio-Techne's Total Current Liabilities stood at $154.8 million in 2021, then decreased by 17.06% to $128.4 million in 2022, then increased by 5.32% to $135.2 million in 2023, then rose by 19.24% to $161.3 million in 2024, then decreased by 12.92% to $140.4 million in 2025.
- The last three reported values for Total Current Liabilities were $140.4 million (Q4 2025), $144.5 million (Q3 2025), and $175.8 million (Q2 2025) per Business Quant data.